3ª Jornada Mineira de Cancer de Mama

Atividades
Aula
Revistas

Mesa Redonda 01

Coordenador: Clécio Ênio Murta de Lucena

Contracepção e Terapia de reposição Hormonal (TH) da Pós-menopausa em Pacientes com Alto Risco para Câncer de Mama	Ricardo de Melo Marinho
Lesões Mamárias Proliferativas: Impacto no Risco de Câncer de Mama	Felipe Zerwes
Recomendações no Estilo de Vida e sua Relação com o Câncer de Mama	João Henrique Penna Reis

Mesa Redonda 02

Coordenadora: Bárbara Pace Silva de Assis

Abordagem Cirúrgica Axilar Pós Quimioterapia Neo-adjuvante: Onde Estamos?	Antônio Luiz Frasson
Identificação do Linfonodo Sentinela Pré QT Neoadjuvante	Vinícius Budel
Linfonodo Sentinela Positivo Após Mastectomia. Podemos Extrapolar os Dados no ACOSOG Z0011?	Guilherme Novita Garcia
Radioterapia no Câncer de Mama com LS Positivo – O Que Mudar?	Stella Sala Soares Lima

Mesa Redonda 03

Coordenador: Alexandre Jacome

Câncer de Mama HER2 +: Otimizando o Tratamento Sistêmico em Pacientes com Doença Inicial	Otto Metzger
Manejo de Doença Metastática na Era da Medicina Personalizada	Otto Metzger
Tumor Triplo Negativo: Cirurgia ou Quimioterapia como Estratégia Inicial?	Felipe Zerwes

Mesa Redonda 04

Coordenador: Henrique Lima Couto

Abordagem Atual na Paciente de Alto Risco - Visão do Geneticista	Henrique C.R. Galvão
Avaliação de Risco de Câncer de Mama: Quem Realmente Pode Ser Considerado Alto Risco?	Alessandra Starling
Câncer de Mama nos Extremos da Vida: O Que Mudar na Estratégia Terapêutica?	Guilherme Novita Garcia

Ponto e Contra-Ponto

Coordenadora: Cláudia Márcia

Mastectomia Profilática Contralateral em Pacientes sem Mutação	Cláudia Márcia e Silva

Abordagem Atual na Paciente de Alto Risco - Visão do Geneticista Voltar

Henrique C.R. Galvão

Mesa Redonda 04 - Coordenador: Henrique Lima Couto

Artigo	Autor(es)	Referência
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.	Desmond Andrea, Kurian Allison W, Gabree Michele, Mills Meredith A, Anderson Michael J, Kobayashi Yuya, Horick Nora, Yang Shan, Shannon Kristen M, Tung Nadine, Ford James M, Lincoln Stephen E, Ellisen Leif W	JAMA oncology. 2015 Oct; 1(Oct):943-51. doi: 10.1001/jamaoncol.2015.2690. pii: .
Gene panel testing for hereditary breast cancer.	Winship Ingrid, Southey Melissa C	The Medical journal of Australia. 2016 Mar; 204(Mar):188-90.
Testing for Hereditary Breast Cancer: Panel or Targeted Testing? Experience from a Clinical Cancer Genetics Practice.	Doherty Jennifer, Bonadies Danielle C, Matloff Ellen T	Journal of genetic counseling. 2015 Aug; 24(Aug):683-7. doi: 10.1007/s10897-014-9796-2. pii: .

Breast (Edinburgh, Scotland) (6/2017)

Axillary reverse mapping in N0 patients requiring sentinel lymph node biopsy - A systematic review of the literature and necessity of a randomised study.

Parks R M, Cheung K L

Can we make a portrait of women with inoperable locally advanced breast cancer?

Montagna Giacomo, Schneeberger Andres R, Rossi Lorenzo, Bianchi Micheli Gabriella, Meani Francesco, Imperiali Mauro, Spitale Alessandra, Pagani Olivia

Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis.

Poggio F, Ceppi M, Lambertini M, Bruzzi P, Ugolini D, Bighin C, Levaggi A, Giraudi S, D'Alonzo A, Vaglica M, Blondeaux E, Sertoli M R, Pronzato P, Del Mastro L

Development and validation of a nomogram for predicting survival on the base of modified lymph node ratio in breast cancer patients.

Wen Jiahuai, Yang Yanning, Liu Peng, Ye Feng, Tang Hailin, Huang Xiaojia, Zhong Shaowen, Xie Xiaoming

Efficacy of NEPA (netupitant/palonosetron) across multiple cycles of chemotherapy in breast cancer patients: A subanalysis from two phase III trials.

Rugo Hope S, Rossi Giorgia, Rizzi Giada, Aapro Matti

Evaluation of percutaneous vacuum assisted intact specimen breast biopsy device for ultrasound visualized breast lesions: Upstage rates and long term follow-up for high risk lesions and DCIS.

Graham Cathy L

Feasibility of magnetic marker localisation for non-palpable breast cancer.

Schermers B, van der Hage J A, Loo C E, Vrancken Peeters M T F D, Winter-Warnars H A O, van Duijnhoven F, Ten Haken B, Muller S H, Ruers T J M

Fertility concerns among breast cancer patients in Mexico.

Villarreal-Garza Cynthia, Martinez-Cannon Bertha Alejandra, Platas Alejandra, Mohar Alejandro, Partridge Ann H, Gil-Moran Arnoldo, Fonseca Alan, Vega Yoatzin, Bargallo-Rocha Enrique, Cardona-Huerta Servando, Lopez-Aguirre Yadira Estefany, Barragan-Carrillo Regina, Castro-Sanchez Andrea

Integration of psycho-oncology through the whole care pathway for breast cancer patients in Europe.

Neamţiu L, Deandrea S, Pylkkänen L, Freeman C, López-Alcalde J, Bramesfeld A, Saz-Parkinson Z, Ulutürk A, Lerda D

Secondary gastric cancer malignancies following a breast cancer diagnosis: A population-based analysis.

Mahar Alyson L, Kagedan Daniel J, Hallet Julie, Coburn Natalie G

Suggestion of BRCA1 c.5339T>C (p.L1780P) variant confer from 'unknown significance' to 'Likely pathogenic' based on clinical evidence in Korea.

Ryu Jai Min, Kang Goeun, Nam Seok Jin, Kim Seok Won, Yu Jonghan, Lee Se Kyung, Bae Soo Youn, Park Sungmin, Paik Hyun-June, Kim Jong-Won, Park Sung-Shin, Lee Jeong Eon, Kim Sung-Won

Surgeon performed continuous intraoperative ultrasound guidance decreases re-excisions and mastectomy rates in breast cancer.

Karadeniz Cakmak Guldeniz, Emre Ali U, Tascilar Oge, Bahadir Burak, Ozkan Selcuk

Targeted superparamagnetic nanoparticles coated with 2-deoxy-d-gloucose and doxorubicin more sensitize breast cancer cells to ionizing radiation.

Pirayesh Islamian Jalil, Hatamian Milad, Aval Negar Abbasi, Rashidi Mohammad Reza, Mesbahi Asghar, Mohammadzadeh Mohammad, Asghari Jafarabadi Mohammad

Trial sponsorship and self-reported conflicts of interest in breast cancer radiation therapy: An analysis of prospective clinical trials.

Leite Elton T T, Moraes Fabio Y, Marta Gustavo N, Taunk Neil K, Vieira Marina T L, Hanna Samir A, Silva João Luis F, Carvalho Heloisa A

Update on the diagnosis and management of malignant phyllodes tumors of the breast.

Strode Matthew, Khoury Thaer, Mangieri Christopher, Takabe Kazuaki

Validation of the electronic version of the BREAST-Q in the army of women study.

Fuzesi Sarah, Cano Stefan J, Klassen Anne F, Atisha Dunya, Pusic Andrea L

Breast (Edinburgh, Scotland) (8/2017)

Cancer-related cognitive impairment and its relation to PTSD.

Robins H Ian, Johnson Laddie, LoConte Noelle, Brandt Kimberly

Reply to H. Ian Robins.

Ruano Luis, Pereira Susana, Fontes Filipa, Ramalho Mariana, Lunet Nuno

Breast (Edinburgh, Scotland) (2/2018)

Tumor infiltrating lymphocytes in early breast cancer.

Pruneri Giancarlo, Vingiani Andrea, Denkert Carsten

Breast cancer research and treatment (6/2017)

A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women.

Tseng Ling-Ming, Chiu Jen-Hwey, Liu Chun-Yu, Tsai Yi-Fang, Wang Yun-Lin, Yang Chu-Wen, Shyr Yi-Ming

A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer.

Baselga José, Morales Serafin M, Awada Ahmad, Blum Joanne L, Tan Antoinette R, Ewertz Marianne, Cortes Javier, Moy Beverly, Ruddy Kathryn J, Haddad Tufia, Ciruelos Eva M, Vuylsteke Peter, Ebbinghaus Scot, Im Ellie, Eaton Lamar, Pathiraja Kumudu, Gause Christine, Mauro David, Jones Mary Beth, Rugo Hope S

A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells.

Wu Yanyuan, Tran Trinh, Dwabe Sami, Sarkissyan Marianna, Kim Juri, Nava Miguel, Clayton Sheilah, Pietras Richard, Farias-Eisner Robin, Vadgama Jaydutt V

Aromatase expression in atypical ductal hyperplasia in women.

Santen R J, Radisky D C, Degnim A, Frost M H, Vachon C M, Ghosh K, Guestini F, McNamara K M, Sasano H

Background parenchymal enhancement on breast MRI: association with recurrence-free survival in patients with newly diagnosed invasive breast cancer.

Lim Yaeji, Ko Eun Sook, Han Boo-Kyung, Ko Eun Young, Choi Ji Soo, Lee Jeong Eon, Lee Se Kyung

Basal markers and prognosis in luminal breast cancer.

Engstrøm Monica J, Valla Marit, Bofin Anna M

Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.

Krammer Julia, Pinker-Domenig Katja, Robson Mark E, Gönen Mithat, Bernard-Davila Blanca, Morris Elizabeth A, Mangino Debra A, Jochelson Maxine S

Breast cancer screening in patients with cancers other than breast.

Leopold Robin B, Thomas Alexander W, Concannon Kyle F, Correll Alissa D, LaPenta Catherine M, Maurer Stephen M, Sprague Brian L, Herschorn Sally D, Verschraegen Claire F

Breast cancer subtype distribution is different in normal weight, overweight, and obese women.

Gershuni Victoria, Li Yun R, Williams Austin D, So Alycia, Steel Laura, Carrigan Elena, Tchou Julia

Breast tumor DNA methylation patterns associated with smoking in the Carolina Breast Cancer Study.

Conway Kathleen, Edmiston Sharon N, Parrish Eloise, Bryant Christopher, Tse Chiu-Kit, Swift-Scanlan Theresa, McCullough Lauren E, Kuan Pei Fen

Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study.

Tryfonidis Konstantinos, Marreaud S, Khaled H, De Valk B, Vermorken J, Welnicka-Jaskiewicz M, Aalders K, Bartlett J M S, Biganzoli L, Bogaerts J, Cameron David,

Chemotherapy-induced irreversible alopecia in early breast cancer patients.

Kim Gun Min, Kim Sanghwa, Park Hyung Seok, Kim Jee Ye, Nam Sanggen, Park Seho, Kim Seung Il, Kim DoYoung, Sohn Joohyuk

Cost-effectiveness of palbociclib plus letrozole versus letrozole alone as a first-line treatment in women with oestrogen receptor-positive, HER2-negative, advanced breast cancer. Revised results for the Swiss health care setting.

Matter-Walstra K, Schwenkglenks M, Dedes K J

Detection of ESR1 mutations in plasma and tumors from metastatic breast cancer patients using next-generation sequencing.

Yanagawa Takehiro, Kagara Naofumi, Miyake Tomohiro, Tanei Tomonori, Naoi Yasuto, Shimoda Masafumi, Shimazu Kenzo, Kim Seung Jin, Noguchi Shinzaburo

Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience.

Ciccarese Mariangela, Fabi Alessandra, Moscetti Luca, Cazzaniga Maria Elena, Petrucelli Luciana, Forcignanò Rosachiara, Lupo Laura Isabella, De Matteis Elisabetta, Chiuri Vincenzo Emanuele, Cairo Giuseppe, Febbraro Antonio, Giordano Guido, Giampaglia Marianna, Bilancia Domenico, La Verde Nicla, Maiello Evaristo, Morritti Maria, Giotta Francesco, Lorusso Vito, Latorre Agnese, Scavelli Claudio, Romito Sante, Cusmai Antonio, Palmiotti Gennaro, Surico Giammarco

Estrogen-progestin use and breast cancer characteristics in lean and overweight postmenopausal women.

Kjartansdottir Olof J, Sigurdardottir Lara G, Olafsdottir Elinborg J, Jonasson Jon G, Ursin Giske, Tryggvadottir Laufey

Evaluation of changes to foot shape in females 5 years after mastectomy: a case-control study.

Głowacka-Mrotek Iwona, Sowa Magdalena, Siedlecki Zygmunt, Nowikiewicz Tomasz, Hagner Wojciech, Zegarski Wojciech

FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer.

Hamurcu Zuhal, Kahraman Nermin, Ashour Ahmed, Ozpolat Bulent

Health-related quality of life in Black breast cancer survivors with and without triple-negative breast cancer (TNBC).

Vadaparampil Susan T, Christie Juliette, Donovan Kristine A, Kim Jongphil, Augusto Bianca, Kasting Monica L, Holt Cheryl L, Ashing Kimlin, Halbert Chanita Hughes, Pal Tuya

Identifying socio-demographic and clinical characteristics associated with medication beliefs about aromatase inhibitors among postmenopausal women with breast cancer.

Salgado Teresa M, Davis Emily J, Farris Karen B, Fawaz Souhiela, Batra Peter, Henry N Lynn

Immunoglobulin-like domain 4-mediated ligand-independent dimerization triggers VEGFR-2 activation in HUVECs and VEGFR2-positive breast cancer cells.

Zhang Sheng, Gao Xiaoping, Fu Wei, Li Shengwei, Yue Limin

Is breast compression associated with breast cancer detection and other early performance measures in a population-based breast cancer screening program?

Moshina Nataliia, Sebuødegård Sofie, Hofvind Solveig

Lymphatico-venous anastomosis as treatment for breast cancer-related lymphedema: a prospective study on quality of life.

Cornelissen Anouk J M, Kool Melissa, Lopez Penha Tiara R, Keuter Xavier H A, Piatkowski Andrzej A, Heuts E, van der Hulst René R W J, Qiu Shan Shan

Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression.

Strekalova Elena, Malin Dmitry, Rajanala Harisha, Cryns Vincent L

Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients.

Crawford Beth, Adams Sophie B, Sittler Taylor, van den Akker Jeroen, Chan Salina, Leitner Ofri, Ryan Lauren, Gil Elad, van 't Veer Laura

Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients.

Bingham Catherine, Fernandez Sandra V, Fittipaldi Patricia, Dempsey Paul W, Ruth Karen J, Cristofanilli Massimo, Katherine Alpaugh R

Oncoplastic surgery with omental flap reconstruction: a study of 200 cases.

Munhoz Alexandre Mendonça, Gemperli Rolf, Filassi José Roberto

Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari).

Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita T, Yamamoto Y, Ohno S, Toi M

Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer.

Muti Paola, Secreto Giorgio, Krogh Vittorio

Prognosis of pregnancy-associated breast cancer.

Lee Guek Eng, Mayer Erica L, Partridge Ann

Quality of life in patients with recurrent breast cancer after second breast-conserving therapy in comparison with mastectomy: the German experience.

Jendrian Svenja, Steffens Katharina, Schmalfeldt Barbara, Laakmann Elena, Bergelt Corinna, Witzel Isabell

Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities.

Rauscher Garth H, Silva Abigail, Pauls Heather, Frasor Jonna, Bonini Marcelo G, Hoskins Kent

Relationship of breast MRI to recurrence rates in patients undergoing breast-conservation treatment.

Hill Maureen V, Beeman Julia L, Jhala Khushboo, Holubar Stefan D, Rosenkranz Kari M, Barth Richard J

Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis.

Rugo Hope S, Melin Susan A, Voigt Jeff

Self-reported long-term cardiac morbidity in breast cancer patients: a retrospective cohort study in Germany (PASSOS Heart Study).

Wollschläger Daniel, Merzenich Hiltrud, Schwentner Lukas, Janni Wolfgang, Wiegel Thomas, Bartkowiak Detlef, Wöckel Achim, Schmidt Marcus, Schmidberger Heinz, Blettner Maria

The impact of mastectomy type on the Female Sexual Function Index (FSFI), satisfaction with appearance, and the reconstructed breast's role in intimacy.

Rojas K, Onstad M, Raker C, Clark M A, Stuckey A, Gass J

Treatment of cutaneous metastases of breast cancer with electrochemotherapy: what is the magnitude of clinical benefit?

Campana Luca G, Galuppo Sara, Valpione Sara

Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials.

Dieci M V, Frassoldati A, Generali D, Bisagni G, Piacentini F, Cavanna L, Cagossi K, Puglisi F, Michelotti A, Berardi R, Banna G, Goubar A, Ficarra G, Griguolo G, Conte Pierfranco, Guarneri V

Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503).

Kimmick Gretchen G, Major Brittny, Clapp Jonathan, Sloan Jeff, Pitcher Brandelyn, Ballman Karla, Barginear Myra, Freedman Rachel A, Artz Andrew, Klepin Heidi D, Lafky Jacqueline M, Hopkins Judith, Winer Eric, Hudis Clifford, Muss Hyman, Cohen Harvey, Jatoi Aminah, Hurria Arti, Mandelblatt Jeanne

ΔNp63 activates EGFR signaling to induce loss of adhesion in triple-negative basal-like breast cancer cells.

Holcakova Jitka, Nekulova Marta, Orzol Paulina, Nenutil Rudolf, Podhorec Jan, Svoboda Marek, Dvorakova Petra, Pjechova Mariana, Hernychova Lenka, Vojtesek Borivoj, Coates Philip J

Breast cancer research and treatment (7/2017)

Adherence to guidelines and breast cancer patients survival: a population-based cohort study analyzed with a causal inference approach.

Andreano Anita, Rebora Paola, Valsecchi Maria Grazia, Russo Antonio Giampiero

Breast cancer in Asian Americans in California, 1988-2013: increasing incidence trends and recent data on breast cancer subtypes.

Gomez Scarlett Lin, Von Behren Julie, McKinley Meg, Clarke Christina A, Shariff-Marco Salma, Cheng Iona, Reynolds Peggy, Glaser Sally L

DNA methylation age is elevated in breast tissue of healthy women.

Sehl Mary E, Henry Jill E, Storniolo Anna Maria, Ganz Patricia A, Horvath Steve

Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.

Truin Wilfred, Roumen Rudi M H, Siesling Sabine, van de Vijver Koen K, Tjan-Heijnen Vivianne C G, Voogd Adri C

Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance).

Mandelblatt Jeanne S, Cai Ling, Luta George, Kimmick Gretchen, Clapp Jonathan, Isaacs Claudine, Pitcher Brandeyln, Barry William, Winer Eric, Sugarman Stephen, Hudis Clifford, Muss Hyman, Cohen Harvey J, Hurria Arti

Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro.

Thomas Lynn N, Chedrawe Emily R, Barnes Penelope J, Too Catherine K L

The breast journal (3/2017)

A Case of Adenomyoepithelioma of the Breast Showing Strong Uptake of 18 F-Fluorodeoxyglucose on a Positron Emission Tomography.

Oba Takaaki, Maeno Kazuma, Ono Mayu, Iesato Asumi, Ito Tokiko, Kanai Toshiharu, Mochizuki Yasuhiro, Ito Ken-Ichi, Yoshizawa Akihiko, Takayama Fumiyoshi

Fibroepithelial Lesions in the Breast of Adolescent Females: A Clinicopathological Study of 54 Cases.

Ross Dara S, Giri Dilip D, Akram Muzaffar M, Catalano Jeffrey P, Olcese Cristina, Van Zee Kimberly J, Brogi Edi

Lymphocytic Mastopathy: Mimicker of Breast Malignancy.

Yilmaz Ravza, Yesil Semen, Bayramoglu Zuhal, Ozkurt Enver, Acunas Gulden

Putting Breast Cancer Patients First.

Grobmyer Stephen R, Abraham Jame

The Relationship of Race, Oncotype DX, and Ki67 in a Population Highly Screened For Breast Cancer.

Guth Amber A, Chun Kim Jennifer, Schwartz Shira, Montes Jennifer, Snyder Rebecca Akiko, Axelrod Deborah, Schnabel Freya

The breast journal (9/2017)

A Population-Based Cross-Sectional Study Comparing Breast Cancer Stage at Diagnosis between Immigrant and Canadian-Born Women in Ontario.

Iqbal Javaid, Ginsburg Ophira, Fischer Hadas D, Austin Peter C, Creatore Maria I, Narod Steven A, Rochon Paula A

Abnormal BI-RADS Breast Lesions in Gabon.

Ivanga Mahinè, Koumakpayi Ismaël H, Engohan-Aloghe Corinne, Ebinda Mipinda Gaëlle, Mboumba Chermine, Chansy K Ankely Junie, Belembaogo Ernest

Anxiety and Breast Imaging--Can Community Education by a Breast Radiologist Decrease Anxiety and Improve Knowledge?

Lourenco Ana P, Baird Grayson L

Are the ACOSOG Z0011 Trial Findings Being Applied to Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy?

Kantor Olga, Pesce Catherine, Liederbach Erik, Wang Chi-Hsiung, Winchester David J, Yao Katharine

Imaging Findings of A Rare Breast Malignancy: Bilateral Metachronous Primary Angiosarcoma of Breast.

Bayramoglu Zuhal, Yılmaz Ravza, Demir Ali Aslan, Ozturk Sari Sule, Maulid Payam, Bozbey Hamza U, Acunas Gulden

Low Compliance in a Health-Conscience Spending Era Likely Helps Obviates the Need for 6 month BI-RADS 3 Breast MRI Follow-up After 1 year.

Mosier Andrew, Gupta Esha, Ataya Dana, Bhatt Kavita, Rim Alice

Novel Wireless Cardiac Monitor Located in the Breast: Imaging Appearance and Function.

Mayo Ray C, Leung Jessica

Organized Breast Seroma Mimicking Local Tumor Recurrence.

Rotaru Natalia, Punga Janna, Crivceanschii Maxim, Codreanu Ion

Osteonecrosis of the Jaw in a Breast Cancer Patient Treated with Everolimus and a Single Dose of Zoledronic Acid.

Omarini Claudia, Filieri Maria E, Depenni Roberta, Grizzi Giulia, Cascinu Stefano, Piacentini Federico

Pathologic Predictors of Treatment Response to Neo-adjuvant Chemotherapy for Invasive Lobular Breast Carcinoma.

Tsai Michaela, Finkelstein Marsha, Lillemoe Tamera, Susnik Barbara, Grimm Erin, Kang Sung-Hae, Kelly Caitlin, Swenson Karen

Primary Neuroendocrine Carcinoma of the Breast Metastatic to the Bones, Which Chemotherapy?

Soe Aye M, Joseph Gardith, Guevara Elizabeth, Xiao Philip

Relation between Hypofractionated Radiotherapy, Toxicity and Outcome in Early Breast Cancer.

De Felice Francesca, Ranalli Tiziana, Musio Daniela, Lisi Roberto, Rea Federica, Caiazzo Rossella, Tombolini Vincenzo

Relationships Between MRI Breast Imaging-Reporting and Data System (BI-RADS) Lexicon Descriptors and Breast Cancer Molecular Subtypes: Internal Enhancement is Associated with Luminal B Subtype.

Grimm Lars J, Zhang Jing, Baker Jay A, Soo Mary S, Johnson Karen S, Mazurowski Maciej A

Revisiting an Old Place: Single-Surgeon Experience on Post-Mastectomy Subcutaneous Implant-Based Breast Reconstruction.

Woo Alice, Harless Christin, Jacobson Steven R

Specimen Identification Errors in Breast Biopsies: Age Matters. Report of Two Near-Miss Events and Review of the Literature.

Tozbikian Gary, Gemignani Mary L, Brogi Edi

The Impact of Mental Illness on Uptake of Genetic Counseling for Hereditary Breast Cancer and Ovarian Cancer in a Multiethnic Cohort of Breast Cancer Patients.

Ackerman Marra G, Shapiro Peter A, Coe Austin, Trivedi Meghna S, Crew Katherine D

Treatment of Breast Hypoplasia in Becker Nevus Syndrome.

Nunes Rodrigo Barboza, Silva Marcelo Felix da, Coltro Pedro Soler, Lima Renan Victor Kümpel Schmidt, Farina Jayme Adriano

Upgrade Rate and Imaging Features of Atypical Apocrine Lesions.

Chang Sen Lauren Q, Berg Wendie A, Carter Gloria J

With the Advent of Tomosynthesis in the Workup of Mammographic Abnormality, is Spot Compression Mammography Now Obsolete? An Initial Clinical Experience.

Ni Mhuircheartaigh Neasa, Coffey Louise, Fleming Hannah, O' Doherty Ann, McNally Sorcha

The breast journal (11/2017)

Extended Adjuvant Endocrine Therapy in Breast Cancer: Evidence and Update - A Review.

Jinih Marcel, Relihan Norma, Corrigan Mark A, O'Reilly Seamus, Redmond Henry P

Feasibility of Intraoperative Breast MRI and the Role of Prone Versus Supine Positioning in Surgical Planning for Breast-Conserving Surgery.

Mallory Melissa A, Sagara Yasuaki, Aydogan Fatih, DeSantis Stephen, Jayender Jagadeesan, Caragacianu Diana, Gombos Eva, Vosburgh Kirby G, Jolesz Ferenc A, Golshan Mehra

The breast journal (5/2017)

Higher Pretreatment and Aromatase Inhibitor Treatment-Related Cardiovascular Disease Risks in Postmenopausal Hormone Receptor-Positive Patients with Early Stage Breast Cancer.

Altundag Kadri

Response to Dr. Altundag's Letter to the Editor.

Gallicchio Lisa, Calhoun Carla, Riseberg David, Helzlsouer Kathy

The breast journal (7/2017)

Insomnia in the Cancer Patient: A Complex Problem.

Mahtani Reshma L